Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark

Peer Michael Christiansen; Karsten Bjerre; Bent Ejlertsen; Maj-Britt Jensen; Birgitte B Rasmussen; Anne-Vibeke Lænkholm; Niels Kroman; Marianne Ewertz; Birgitte Vrou Offersen; Dorte B Toftdahl; Susanne Møller; Henning T Mouridsen; Danish Breast Cancer Cooperative Group

doi:10.1093/jnci/djr299

Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark

Peer Michael Christiansen, Karsten Bjerre, Bent Ejlertsen, Maj-Britt Jensen, Birgitte B Rasmussen, Anne-Vibeke Lænkholm, Niels Kroman, Marianne Ewertz, Birgitte Vrou Offersen, Dorte B Toftdahl, Susanne Møller, Henning T Mouridsen, Danish Breast Cancer Cooperative Group

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

51 Citationer (Scopus)

Abstract

Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.

Originalsprog	Engelsk
Tidsskrift	National Cancer Institute. Journal (Print)
Vol/bind	103
Udgave nummer	18
Sider (fra-til)	1363-1372
ISSN	0027-8874
DOI	https://doi.org/10.1093/jnci/djr299
Status	Udgivet - 2011

Adgang til dokumentet

10.1093/jnci/djr299

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Christiansen, P. M., Bjerre, K., Ejlertsen, B., Jensen, M.-B., Rasmussen, B. B., Lænkholm, A.-V., Kroman, N., Ewertz, M., Offersen, B. V., Toftdahl, D. B., Møller, S., Mouridsen, H. T., & Danish Breast Cancer Cooperative Group (2011). Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. National Cancer Institute. Journal (Print), 103(18), 1363-1372. https://doi.org/10.1093/jnci/djr299

Christiansen, PM, Bjerre, K, Ejlertsen, B, Jensen, M-B, Rasmussen, BB, Lænkholm, A-V, Kroman, N, Ewertz, M, Offersen, BV, Toftdahl, DB, Møller, S, Mouridsen, HT & Danish Breast Cancer Cooperative Group 2011, 'Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark', National Cancer Institute. Journal (Print), bind 103, nr. 18, s. 1363-1372. https://doi.org/10.1093/jnci/djr299

@article{801e008081ac4660b5992c9647753b21,

title = "Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark",

abstract = "Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.",

author = "Christiansen, {Peer Michael} and Karsten Bjerre and Bent Ejlertsen and Maj-Britt Jensen and Rasmussen, {Birgitte B} and Anne-Vibeke L{\ae}nkholm and Niels Kroman and Marianne Ewertz and Offersen, {Birgitte Vrou} and Toftdahl, {Dorte B} and Susanne M{\o}ller and Mouridsen, {Henning T} and Kroman, {Niels Thorndahl}",

year = "2011",

doi = "10.1093/jnci/djr299",

language = "English",

volume = "103",

pages = "1363--1372",

journal = "National Cancer Institute. Journal (Print)",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "18",

}

TY - JOUR

T1 - Mortality rates among early-stage hormone receptor-positive breast cancer patients

T2 - a population-based cohort study in Denmark

AU - Christiansen, Peer Michael

AU - Bjerre, Karsten

AU - Ejlertsen, Bent

AU - Jensen, Maj-Britt

AU - Rasmussen, Birgitte B

AU - Lænkholm, Anne-Vibeke

AU - Kroman, Niels

AU - Ewertz, Marianne

AU - Offersen, Birgitte Vrou

AU - Toftdahl, Dorte B

AU - Møller, Susanne

AU - Mouridsen, Henning T

AU - Danish Breast Cancer Cooperative Group

PY - 2011

Y1 - 2011

N2 - Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.

AB - Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.

U2 - 10.1093/jnci/djr299

DO - 10.1093/jnci/djr299

M3 - Journal article

SN - 0027-8874

VL - 103

SP - 1363

EP - 1372

JO - National Cancer Institute. Journal (Print)

JF - National Cancer Institute. Journal (Print)

IS - 18

ER -